A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer Article

sustainable development goals

publication date

  • October 7, 2020

webpage

published in

keywords

  • Abiraterone
  • Androgen-receptor signaling pathway inhibitors
  • Castration-resistant prostate cancer
  • Claims
  • Enzalutamide
  • Immunotherapy
  • Metastatic
  • Multivariable analysis
  • Sipuleucel-T